IL163896A0 - Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5) - Google Patents
Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5)Info
- Publication number
- IL163896A0 IL163896A0 IL16389603A IL16389603A IL163896A0 IL 163896 A0 IL163896 A0 IL 163896A0 IL 16389603 A IL16389603 A IL 16389603A IL 16389603 A IL16389603 A IL 16389603A IL 163896 A0 IL163896 A0 IL 163896A0
- Authority
- IL
- Israel
- Prior art keywords
- receptoractivity
- chemokine
- aza
- modulators
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200919A SE0200919D0 (sv) | 2002-03-25 | 2002-03-25 | Chemical compounds |
| PCT/SE2003/000480 WO2003080574A1 (en) | 2002-03-25 | 2003-03-24 | Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163896A0 true IL163896A0 (en) | 2005-12-18 |
Family
ID=20287391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16389603A IL163896A0 (en) | 2002-03-25 | 2003-03-24 | Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5) |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050171353A1 (es) |
| EP (1) | EP1490336A1 (es) |
| JP (1) | JP2005526797A (es) |
| KR (1) | KR20040094876A (es) |
| CN (1) | CN1642913A (es) |
| AR (1) | AR039125A1 (es) |
| AU (1) | AU2003216012A1 (es) |
| BR (1) | BR0308592A (es) |
| CA (1) | CA2479887A1 (es) |
| IL (1) | IL163896A0 (es) |
| MX (1) | MXPA04009162A (es) |
| NO (1) | NO20044545L (es) |
| SE (1) | SE0200919D0 (es) |
| TW (1) | TW200305417A (es) |
| WO (1) | WO2003080574A1 (es) |
| ZA (1) | ZA200407414B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
| SE0301369D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
| SE0302090D0 (sv) * | 2003-07-16 | 2003-07-16 | Astrazeneca Ab | Chemical compounds |
| US7498346B2 (en) * | 2003-12-11 | 2009-03-03 | Genzyme Corporation | Chemokine receptor binding compounds |
| SE0303396D0 (sv) * | 2003-12-16 | 2003-12-16 | Astrazeneca Ab | Chemical compounds |
| TW200538098A (en) * | 2004-03-22 | 2005-12-01 | Astrazeneca Ab | Therapeutic agents |
| ES2277745B1 (es) * | 2005-06-14 | 2008-06-01 | Laboratorios Almirall S.A. | Derivados n-amida de 8-azabiciclo /3.2.1/oct-3-ilo como antagonistas de ccr1. |
| JP2008543858A (ja) * | 2005-06-15 | 2008-12-04 | ジェンザイム・コーポレーション | ケモカインレセプター結合化合物 |
| MX2008001067A (es) * | 2005-08-01 | 2008-03-19 | Astrazeneca Ab | Derivados de piperidina novedosos como moduladores de receptor de quimioquina utiles para el tratamiento de enfermedades respiratorias. |
| BRPI0617720A2 (pt) | 2005-10-19 | 2011-08-02 | Hoffmann La Roche | compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém |
| CA2658984C (en) | 2006-08-16 | 2014-12-02 | Joshua Kennedy-Smith | Non-nucleoside reverse transcriptase inhibitors |
| BRPI0720436A2 (pt) | 2006-12-13 | 2014-01-07 | Hoffmann La Roche | Inibidores de transcriptase reversa de não-nucleosídeo |
| WO2009010478A2 (en) * | 2007-07-13 | 2009-01-22 | Euroscreen S.A. | Use of piperidine derivatives as agonists of chemokine receptor activity |
| CN101412692B (zh) * | 2007-10-18 | 2012-10-17 | 中国科学院上海药物研究所 | 1-(3-氨基丙基)哌啶-4-氨基酰胺类化合物、其药物组合物及其制备方法和用途 |
| CN101712679B (zh) | 2008-10-08 | 2013-04-10 | 中国科学院上海药物研究所 | 一种酰胺类化合物、其药物组合物及其制备方法和用途 |
| CN102140104B (zh) * | 2010-02-03 | 2014-11-12 | 中国科学院上海药物研究所 | 1-(3-(s)-氨基丙基)-哌啶-4-氨基酰胺类化合物、其药物组合物及其制备方法和用途 |
| WO2012113103A1 (en) | 2011-02-25 | 2012-08-30 | Helsinn Healthcare S.A. | Asymmetric ureas and medical uses thereof |
| CN106977511B (zh) * | 2011-12-19 | 2019-04-12 | 中国科学院上海药物研究所 | 一种氨基丙基取代托烷胺类化合物、其药物组合物及其制备方法和用途 |
| CA3017048C (en) | 2016-03-22 | 2023-11-07 | Helsinn Healthcare Sa | Benzenesulfonyl-asymmetric ureas and medical uses thereof |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1013276A1 (en) * | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalkanes as CCR5 modulators |
| AU5473800A (en) * | 1999-06-11 | 2001-01-02 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
| SE9902987D0 (sv) * | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| GB0011838D0 (en) * | 2000-05-17 | 2000-07-05 | Astrazeneca Ab | Chemical compounds |
| SI1284974T1 (en) * | 2000-05-26 | 2004-08-31 | Pfizer Inc. | Triazolyl tropane derivatives as ccr5 modulators |
| US20040110952A1 (en) * | 2001-03-01 | 2004-06-10 | Jeremy Burrows | N-4-piperidinyl compounds as ccr5 modulators |
| GB0107228D0 (en) * | 2001-03-22 | 2001-05-16 | Astrazeneca Ab | Chemical compounds |
-
2002
- 2002-03-25 SE SE0200919A patent/SE0200919D0/xx unknown
-
2003
- 2003-03-17 TW TW092105784A patent/TW200305417A/zh unknown
- 2003-03-24 IL IL16389603A patent/IL163896A0/xx unknown
- 2003-03-24 CN CNA038064642A patent/CN1642913A/zh active Pending
- 2003-03-24 WO PCT/SE2003/000480 patent/WO2003080574A1/en active Application Filing
- 2003-03-24 EP EP03745059A patent/EP1490336A1/en not_active Withdrawn
- 2003-03-24 CA CA002479887A patent/CA2479887A1/en not_active Abandoned
- 2003-03-24 MX MXPA04009162A patent/MXPA04009162A/es not_active Application Discontinuation
- 2003-03-24 KR KR10-2004-7015310A patent/KR20040094876A/ko not_active Application Discontinuation
- 2003-03-24 US US10/508,895 patent/US20050171353A1/en not_active Abandoned
- 2003-03-24 BR BR0308592-9A patent/BR0308592A/pt not_active Application Discontinuation
- 2003-03-24 JP JP2003578329A patent/JP2005526797A/ja active Pending
- 2003-03-24 AU AU2003216012A patent/AU2003216012A1/en not_active Abandoned
- 2003-03-25 AR ARP030101026A patent/AR039125A1/es unknown
-
2004
- 2004-09-15 ZA ZA200407414A patent/ZA200407414B/en unknown
- 2004-10-22 NO NO20044545A patent/NO20044545L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04009162A (es) | 2004-12-07 |
| AR039125A1 (es) | 2005-02-09 |
| AU2003216012A1 (en) | 2003-10-08 |
| KR20040094876A (ko) | 2004-11-10 |
| TW200305417A (en) | 2003-11-01 |
| NO20044545L (no) | 2004-12-13 |
| CA2479887A1 (en) | 2003-10-02 |
| EP1490336A1 (en) | 2004-12-29 |
| WO2003080574A1 (en) | 2003-10-02 |
| ZA200407414B (en) | 2005-08-29 |
| SE0200919D0 (sv) | 2002-03-25 |
| JP2005526797A (ja) | 2005-09-08 |
| CN1642913A (zh) | 2005-07-20 |
| US20050171353A1 (en) | 2005-08-04 |
| BR0308592A (pt) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163896A0 (en) | Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5) | |
| HK1039330A1 (en) | Piperidine derivatives useful as ccr5 antagonists. | |
| AU2003253535A1 (en) | N-4-piperidinyl compounds as ccr5 modulators | |
| HK1062559A1 (en) | Piperidine derivatives useful as modulators of chemokine receptor activity | |
| IL143510A0 (en) | Piperidines as ccr5 modulators | |
| HK1061563A1 (en) | Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv | |
| PL377768A1 (pl) | Nowe pochodne piperydyny jako modulatory receptora CCR5 dla chemokin | |
| IL161699A0 (en) | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) | |
| IL165389A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| AU2001284471A1 (en) | Compositions for improving mental concentration | |
| AU2003212770A1 (en) | Piperidine derivatives useful as modulators of chemokine receptor activity | |
| IL161594A0 (en) | Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) | |
| AU2002241873A1 (en) | Whitening compositions containing ascomycete derived enzyme | |
| AU2003288854A1 (en) | Novel piperidine derivatives as modulators of chemokine receptor ccr5 | |
| IL157713A0 (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
| AU1018801A (en) | Use of 3,4-substituted piperidines | |
| HUP0201281A3 (en) | (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| AU2001253521A1 (en) | Haplotypes of the cxcr4 gene | |
| AU2001276919A1 (en) | Haplotypes of the mmp13 gene | |
| AU2003301095A1 (en) | 4(spiropiperidinyl)methyl substituted pyrrolidines as modulators of chemokine receptor activity | |
| AU2002308369A1 (en) | 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof | |
| AU2001249798A1 (en) | Haplotypes of the ccr5 gene | |
| AU2002321969A1 (en) | Piperidine derivatives useful as modulators of chemokine receptor activity | |
| AU2002249713A1 (en) | Novel piperidine derivatives as modulators of chemokine receptor | |
| SI1421075T1 (sl) | Derivati piperidina, koristni kot antagonisti CCR5 |